Cargando…
Circumvention of Mcl-1-Dependent Drug Resistance by Simultaneous Chk1 and MEK1/2 Inhibition in Human Multiple Myeloma Cells
The anti-apoptotic protein Mcl-1 plays a major role in multiple myeloma (MM) cell survival as well as bortezomib- and microenvironmental forms of drug resistance in this disease. Consequently, there is a critical need for strategies capable of targeting Mcl-1-dependent drug resistance in MM. The pre...
Autores principales: | Pei, Xin-Yan, Dai, Yun, Felthousen, Jessica, Chen, Shuang, Takabatake, Yukie, Zhou, Liang, Youssefian, Leena E., Sanderson, Michael W., Bodie, Wesley W., Kramer, Lora B., Orlowski, Robert Z., Grant, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942309/ https://www.ncbi.nlm.nih.gov/pubmed/24594907 http://dx.doi.org/10.1371/journal.pone.0089064 |
Ejemplares similares
-
Chk1, Chk2, is the amplifier on?
por: Dove, Alan W.
Publicado: (2001) -
MEK and MCL-1 sequential inhibition synergize to enhance rhabdomyosarcoma treatment
por: Alcon, Clara, et al.
Publicado: (2022) -
miR-107 Activates ATR/Chk1 Pathway and Suppress Cervical Cancer Invasion by Targeting MCL1
por: Zhou, Chengyan, et al.
Publicado: (2014) -
Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma
por: Al-Odat, Omar S., et al.
Publicado: (2021) -
Erratum: Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma
Publicado: (2021)